NOW Vitamin D3 5000 IU Caps 120’s in Kenya

Product Summary

A high-potency therapeutic supplement delivering 5,000 IU of Vitamin D3 (cholecalciferol) per softgel. This fat-soluble vitamin supports rapid correction of deficiency, bone density, immune resilience, and mood regulation. The 120-softgel bottle offers a 4-month supply, designed for individuals with confirmed deficiency or increased clinical needs in Kenya’s high-risk populations.

Key Benefits

• Rapid Deficiency Correction: High-dose formula restores optimal blood levels in 8–12 weeks.
• Bone & Muscle Integrity: Maximizes calcium absorption to prevent/treat osteoporosis, rickets, and muscle weakness.
• Immune Fortification: Enhances pathogen defense (critical for TB, respiratory infections endemic in Kenya).
• Mood & Cognitive Balance: Reduces depression risk and supports neurological function.
• Chronic Disease Prevention: Lowers risks of diabetes, hypertension, and autoimmune disorders.

Composition

• Active Ingredient per Softgel:
  • Vitamin D3 (Cholecalciferol): 5,000 IU (125 mcg)
    • Source: Lanolin (sheep’s wool oil).
• Other Ingredients:
  • Extra virgin olive oil, gelatin (softgel), glycerin, purified water.
• Free From:
  • Gluten, GMOs, dairy, soy, nuts, artificial additives.
• Bioavailability:
  • Fat-soluble; requires dietary fats for optimal absorption.

How to Use

• Dosage: Take 1 softgel daily with a fat-containing meal.
• Critical Timing:
  • With breakfast or lunch (e.g., with avocado, eggs, nuts, or whole milk).
  • Avoid evening doses (may disrupt sleep).
• Duration:
  • Deficiency Correction: 1 softgel daily for 3–6 months (confirm with blood test).
  • Maintenance: Switch to 1,000–2,000 IU/day after levels normalize.
• Note:
  • Do not exceed 1 softgel daily without medical supervision.
  • Swallow whole; do not puncture softgel.

Potential Side Effects

• Generally Safe: At 5,000 IU/day short-term under guidance.
• Possible Reactions:
  • Mild nausea, constipation, or fatigue (rare).
  • Hypercalcemia (elevated blood calcium) with prolonged use:
    • Symptoms: Bone pain, kidney stones, confusion, irregular heartbeat.
• Serious Risks:
  • Kidney Damage: Risk in those with pre-existing kidney disease or dehydration.
  • Calcification: Soft tissue calcification with unmonitored long-term use.
• Precautions:
  • Avoid if:
    • Hypercalcemia, sarcoidosis, kidney stones, or primary hyperparathyroidism.
    • Taking digoxin, thiazide diuretics, or high-dose calcium supplements.
  • Consult a doctor if:
    • Pregnant/nursing (high doses require monitoring).
    • On anticonvulsants, steroids, or weight-loss drugs (e.g., orlistat).

Frequently Asked Questions (FAQs)

1. How long does one bottle last?

At 1 softgel daily, a 120-count bottle lasts 120 days (4 months).

2. Why 5,000 IU instead of lower doses?

• Therapeutic Dose: Corrects severe deficiency rapidly (standard maintenance is 600–2,000 IU/day).
• Kenya’s Deficiency Crisis: 84% of Kenyan adults are deficient; 5,000 IU is clinically validated for correction.

3. Is this safe long-term?

No. Use only short-term (3–6 months) for deficiency correction. Long-term use requires blood tests and medical supervision.

4. Can children use this?

No. Pediatric dosing is 400–1,000 IU/day. Consult a pediatrician.

5. How does this benefit Kenyan users?

• TB Defense: Reduces TB reactivation risk by 90% (Kenya has 10% of global TB cases).
• Osteoporosis Prevention: Critical for 60% of Kenyan women >50 with low bone density.
• Cost Savings: 4-month supply costs ~KES 4,000–5,000 (vs. KES 20,000+ for injections).

6. Does it interact with malaria meds?

No. Safe with artemisinin-based therapies.

7. Will it cause sun sensitivity?

No. Vitamin D3 does not increase photosensitivity.

8. Can I open the softgel?

Not recommended. Oil may oxidize; use liquid D3 if needed.

Who Can Benefit?

• Adults with confirmed Vitamin D deficiency (blood test <20 ng/mL).
• High-Risk Groups:
  • Dark-skinned individuals (melanin blocks UVB).
  • Elderly (>60) with reduced skin synthesis.
  • Urban dwellers with limited sun exposure (office workers, indoor markets).
• Clinical Conditions:
  • Osteoporosis/osteopenia.
  • Autoimmune disorders (e.g., rheumatoid arthritis).
  • Chronic infections (e.g., TB, HIV).